News | January 06, 2010

OCT Intravascular Imaging System Granted European Clearance

Volcano's OCT system can show stent strut apposition against the vessel wall.

January 6, 2010 – European CE mark clearance was granted this week for the Volcano OCT (optical coherence tomography) imaging system and catheter. Volcano said its OCT system will be commercially available in Europe in early 2011.

The OCT product line will complement the company’s existing line of IVUS imaging catheters and pressure guide wires used for coronary imaging and lesion assessment.

Volcano acquired its initial OCT technology through the acquisition of CardioSpectra Inc. in December 2007 and has been involved in numerous clinical studies in Europe and South America. The company has submitted an FDA investigational device exemption (IDE) to conduct studies in the United States and South America as part of a U.S. regulatory trial in 2010.

The company plans to incorporate OCT functionality into its s5i IVUS (intravascular ultrasound) integrated platform, as well as stand-alone OCT systems.

“This is an important milestone in the translation of OCT imaging to everyday patient care,” said Marc D. Feldman, M.D., professor of medicine and director of the cath lab at UTHSC San Antonio, Texas. “As cardiologists, we spend billions of dollars every year on coronary stents which have been proven to benefit patients. Technologies like OCT should help us better select the most significant blockages to treat, and help us ensure these stents are placed properly."

OCT is a light-based imaging technology designed to image the coronary artery for image guided PCI, lumen and stent assessments, visualizing thrombus and dissections, and to help assess intimal coverage in previously placed stents. It can also allow physicians to evaluate lesion cap thickness down into the 15-micron range.

Volcano is already working on its next generation OCT system that uses a high definition swept source (HDSS) light source to enable scans of the proximal two-thirds of the coronary artery in as little as one second. The new system will be called the Low Volume OCT (LVOCT) imaging system. Developing the LVOCT will also allowing interventional cardiologists to acquire OCT images during a routine coronary angiographic injection. This extremely low flush volume is expected to allow for optimal imaging while maximizing patient safety, clinical utility and ease-of-use.

For more information: www.volcanocorp.com

Related Content

Philips Showcases Integrated Vascular Solutions at VIVA 2017
News | Peripheral Artery Disease (PAD)| September 13, 2017
Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference in Las Vegas from...
Philips Announces Relaunch of Pioneer Plus IVUS-Guided Catheter
News | Chronic Total Occlusion (CTO)| June 28, 2017
June 28, 2017 — Royal Philips recently announced the relaunch of its Pioneer Plus...
Avinger, VISION Study, two-year outcomes, LINC, Lumivascular technology, Pantheris, OCT-guided atherectomy
News | Atherectomy Devices| February 03, 2017
Avinger Inc. recently announced positive two-year clinical data from the pivotal VISION study of the company’s...
Avinger, Lightbox L250 imaging console, upgrade, Lumivascular platform, OCT, optical coherence tomography
Technology | Intravascular Imaging| January 11, 2017
January 11, 2017 — Avinger Inc. recently announced the U.S.
Sponsored Content | Videos | TCT| November 18, 2016
DAIC Editor Dave Fornell takes a video tour of some of the most innovative new interventional cardiology technologies
OCT stent strut coverage

OCT imaging showing neointimal tissue coverage of metallic stent struts.

News | Stents| November 07, 2016
November 7, 2016 – Results from TRANSFORM-OCT, a prospective, randomized trial using optical coherence tomography (OC
COLOR trial, TCT, NIRS, stenting vulnerable plaques, near infrared spectroscopy

An intravascular ultrasound image (IVUS) with co-registered NIRS showing yellow for the detection of lipid rich plaque in a coronary artery. 

News | Cath Lab| November 07, 2016
November 7, 2016 – Two-year results from the COLOR Trial, the first large-scale multicenter prospective study of its
OCT, optical coherence tomography, coronary stent implantation, superior resolution, TCT 2016, ILLUMIEN III OPTIMIZE PCI Trial
News | Optical Coherence Tomography (OCT)| October 31, 2016
Optical coherence tomography (OCT) provides safe and improved guidance for patients undergoing percutaneous coronary...
Avinger, Pantheris atherectomy catheter, OCT, Lumivascular technology, expanded FDA indication, diagnostic imaging device
News | Atherectomy Devices| October 20, 2016
Avinger Inc. recently announced that the company has received expanded indications from the U.S. Food and Drug...
Overlay Init